Araris Biotech

Developer of novel antibody-drug conjugate linker technology

placeZurich, Zurich, Switzerland calendar_todayFounded 2019 groups24 employees language ararisbiotech.com

Registered entities

Innovation

2 patent families (2 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace dormant. Cited 11 times.

YearFilings
20181
20191

Social engagement

Social engagement: 9.3K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

10 investors on record; lead investors include Redalpine, Schroders Capital, VI Partners, 4Bio Capital; 1 has since exited.

Investor typeCountShare
Venture capital660%
Angel & family office110%
Other / undisclosed330%

Recent activity

23 Jun 2026
Milestone
regulatory
10 Jun 2026
Event
BIO 2026 partnering conference
1 Jun 2026
Event
5th World ADC Korea 2026
Coming soon